论文部分内容阅读
上海旭东海普药业有限公司今年第一季度生产形势喜人。完成工业总产值6560.7万元,同比增长63.7％,占年度计划的27.34％;完成销售产值2428.8万元,同比增长11.35％,占年度计划的21.1％,但产销率略有下降;新产品产值完成794.5万元,同比增长82.14％,实现利润和成品率同比都有较大增长。 各类剂型的产量除针剂、胶囊增长幅度较大外,片
Shanghai Xudong Haipu Pharmaceutical Co., Ltd. produced a gratifying situation in the first quarter of this year. Completed industrial output value of 65.607 million yuan, an increase of 63.7%, accounting for 27.34% of the annual plan; completed sales value of 24.288 million yuan, an increase of 11.35%, accounting for 21.1% of the annual plan, but the production and sales rate has declined slightly; new product output value is completed 7.945 million yuan, an increase of 82.14% over the same period of last year, achieving a year-on-year increase in profits and product ratios. The output of various types of formulations, apart from injections and capsules, has increased by a large margin.